At the beginning of May, the company Vemax Pharma expanded its range of products with the product Adant by a renowned producer Tedec Meiji (Spain). It is a Na-hyaluronate 25mg/2.5 ml solution, intended for intraarticular administration with patients with osteoarthritis of knees, shoulders, and other synovial joints.

The agreement on business and technical cooperation, i.e. on the provision of outsourcing services in the marketing field, with the company NiMedic Pharm d.o.o. that is an authorised representative of the manufacturer of the product Adant, is the first agreement of this type that Vemax Pharma signed in Serbia.